image
Healthcare - Biotechnology - NASDAQ - US
$ 2.75
-2.83 %
$ 2.43 B
Market Cap
-4.82
P/E
Price Target Average
118.18%
Revenue Forecast Estimate
289.52%
EBIT Estimate
--77.21%
Net Income Estimate
50.71%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets ImmunityBio, Inc.
image
Wall Street analysts predict an average 1-year price target for IBRX of $6 , with forecasts ranging from a low of $6 to a high of $6 .
IBRX Lowest Price Target Wall Street Target
6 USD 118.18%
IBRX Average Price Target Wall Street Target
6 USD 118.18%
IBRX Highest Price Target Wall Street Target
6 USD 118.18%
Price
Max Price Target
Min Price Target
Average Price Target
7766665555444433332222Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart IBRX

image
$3.5b$3.5b$3.0b$3.0b$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart IBRX

image
$0.0$0.0($500.0m)($500.0m)($1.0b)($1.0b)($1.5b)($1.5b)($2.0b)($2.0b)($2.5b)($2.5b)($3.0b)($3.0b)($3.5b)($3.5b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart IBRX

image
$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0($500.0m)($500.0m)($1.0b)($1.0b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029